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ABSTRACT 
 
Ovarian germ cell tumours are very rare and affect mainly young girls and women. Due to this, the conservation of 
reproductive potential is of great concern. One of the most remarkable advances in oncology is in the treatment of 
malignant  ovarian  germ  cell  tumours.  Two  histological  groups  are  distinguished:  dygerminomas,  equivalent  to 
testicular seminomas, and non-dysgerminomatous tumours. We report a case of a 30-year-old nulliparous woman who 
presented with persistent per vaginal bleeding and was found to have a malignant mixed germ cell tumour comprising 
of both embryonal carcinoma and choriocarcinoma. © 2005 Biomedical Imaging and Intervention Journal. All rights 
reserved. 
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INTRODUCTION
        
 
Ovarian germ cell tumours comprise approximately 
15% to 20% of all ovarian neoplasms. They are rapidly 
growing neoplasms that arise from primordial germ cells 
derived from the embryonal gonad. Malignant germ cell 
tumours comprise less than 5% of all ovarian neoplasms. 
The  incidence  of  malignant  ovarian  germ  cell  tumours 
range from 1 to 6 percent as reported in the West and 
from 8 to 19 percent in Asia [1]. Two histological groups 
are distinguished: dygerminomas, equivalent to testicular 
seminomas, and non-dysgerminomatous tumours. 
The  diagnosis  suspected  on  physical  examination, 
relies on pelvic or transvaginal ultrasonography detection 
of a voluminous ovarian mass responsible for abdominal 
discomfort  and/or  swelling.  However,  this  is  only 
confirmed  during  the  initial  surgical  intervention. 
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Tumour markers such as human chorionic gonadotropin 
(HCG)  and  alpha-fetoprotein  also  contribute  to  the 
diagnosis, the prognosis and follow-up of the disease. 
We  present  a  case  of  malignant  mixed  germ  cell 
tumour  comprising  of  embryonal  carcinoma  and 
choriocarcinoma. The term “embryonal carcinoma” was 
used in a study by Kurman et al., as it is analogous to 
embryonal  carcinoma  of  the  adult  testis  and  can  be 
distinguished from the endodermal sinus tumour by its 
distinctive  morphology,  immunohistochemistry,  and 
clinical features [2].  
 
 
CASE REPORT 
 
A  30-year-old  nulliparous  woman  had  significant 
persistent per vaginal bleeding and was seen by a private 
obstetrician. An ultrasound of the pelvis was done and it 
was said to be normal at that time. She was treated with 
progestogens  for  four  cycles  and  her  menstrual  cycle 
resumed to being normal. Six months later she presented 
again with per vaginal bleeding and a repeat ultrasound M. Koshy et al. Biomed Imaging Interv J 2005; 1(2):e10  2 
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revealed  a  pelvic  mass.  A  diagnostic  laparoscopy  was 
then done and deposits were found in both adnexa but no 
biopsy  was  taken.  She  was  once  again  treated  with 
progestogens for two cycles.  
One  month  later  she  presented  again  with  per 
vaginal spotting for four weeks and was then referred to 
the  gynaecology  clinic  at  University  Malaya  Medical 
Centre. She also complained of lower abdominal pain but 
denied any other symptoms. 
Physical  examination  revealed  that  she  had  slight 
pallor  and  was  afebrile.  Vital  signs  were  as  follows: 
blood  pressure  of  107/72  mmHg,  pulse  rate  114  bpm, 
respiration 18/min. She had a distended abdomen with a 
firm,  non-pulsatile,  palpable  mass  in  the  pelvis  and 
extending up to just below the umbilicus. There was mild 
periumbilical  tenderness,  but  no  guarding  or  rebound 
tenderness.  
Rectal  examination was  negative  for  occult  blood, 
and  there  were  no  masses  felt.  There  was  no  inguinal 
adenopathy.  Past  history  revealed  that  she  had 
experienced menarche at age 12. Her menstrual periods 
were described as regular cycles with normal flow. There 
was no family history of any gynaecological cancer. 
 
 
 
Figure  1  Ultrasound  examination  revealed  a  mass  of  mixed 
echogenicity in the right adnexa (arrows). UB = urinary bladder. 
 
 
 
Figure 2 Computed tomography scan of the pelvis revealed a highly 
vascular enhancing mass (arrow) in the pelvis. 
 
Initial laboratory results revealed a normal complete 
blood  count,  electrolytes,  blood  urea,  creatinine  and 
glucose, but a low haemoglobin count of 91.6 g/L. Her 
urine pregnancy test was positive. The patient underwent 
exploratory laparotomy for suspected ectopic pregnancy, 
as  ultrasound  scan  showed  an  enlarged  uterus  with  no 
gestational sac and a right heterogeneous ovarian mass 
measuring  4  cm  x  5cm  x  2.5cm  (Figure  1).  A  right 
ovarian  tumour  with  deposits  on  the  uterus  was  found 
(Figure 2). Right cystectomy was then performed and a 
biopsy of the uterine deposits was taken.  
On gross pathologic examination, sections through 
the  ovary  showed  ‘a  very  haemorrhagic  and  necrotic 
tumour’. Microscopic specimens determined the tumour 
to be a germ cell tumour with embryonal carcinoma and 
choriocarcinoma elements (Figure 3).  
 
 
 
Figure  3  Photomicroscopy  of  mixed  germ  cell  tumour  showing  a 
combination of embryonal carcinoma (arrowhead) and choriocarcinoma 
as evidenced by the presence of a sheet of cytotrophoblasts surrounded 
by syncytiotrophoblasts (arrow) elements. 
 
 
 
Figure  4  Intraoperative  findings  showing  deposits  (arrow)  on  the 
uterine surface. 
 
 
A  thoracic,  abdominal  and  pelvic  computed 
tomography  (CT)  scan  was  then  obtained  to  stage  the 
tumour.  CT  scan  showed  a  highly  vascular  enhancing 
mass in the pelvis measuring 11.4cm × 11.3cm × 11.0cm 
(Figure 4) with multiple hypodense lesions in the liver 
and  pancreas.  There  was  no  abdominal 
lymphadenopathy.  Multiple  hyperdense  nodules  of 
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various sizes were seen throughout both lung fields and 
an  enlarged  pretracheal  lymph  node  was  also  evident. 
The tumour was classified as Stage IV.  
Despite  multiple  chemotherapy  regimes,  serial 
ultrasound five months later showed an enlarged uterus 
measuring 10.0cm × 6.6cm × 9.0cm with two hypodense 
areas within it and a 2.8cm × 4.7cm mass in the pouch of 
Douglas. 
Six months later patient presented to the emergency 
department  with  headache  and  unsteady  gait  for  two 
days.  Computed  tomography  of  the  brain  showed 
hemorrhagic  cerebellar  metastases.  The  patients 
conditioned gradually deteriorated and she succumbed to 
her illness two weeks later. 
 
 
DISCUSSION 
 
Ovarian  germ  cell  neoplasms  are  thought  to  be 
derived  from  primitive  germ  cells  of  the  embryonic 
gonad.  They  constitute  the  second  largest  group 
accounting for 15 to 20 percent of all ovarian neoplasms. 
Malignant  germ  cell  tumours  comprise  less  than  5 
percent of all ovarian neoplasms [3]. In 1973, the World 
Health  Organization  classified  germ  cell  tumours  as 
Dysgerminoma,  Endodermal  sinus  tumour,  Embryonal 
carcinoma, Polyembryoma, Choriocarcinoma, Teratomas 
(Immature,  Mature,  Monodermal),  Mixed  and 
Gonadoblastoma [4]. This initiative represented a major 
advance in terms of standardisation of nomenclature and 
histological criteria.  
These tumours can occur in women at any age, but 
peak incidence is seen during the early 20’s. In children 
and  adolescents,  more  than  60%  of  ovarian  neoplasms 
are of germ cell origin, of which approximately 1/3 are 
malignant.  In  adults,  the  vast  majority  of  germ  cell 
tumours are benign (nearly all mature cystic teratomas).  
Dysgerminoma  is  the  most  common  germ  cell 
tumour,  accounting  for  50%  of  all  germ  cell  tumour 
cases. The yolk sac tumour (also known as endodermal 
sinus  tumour)  is  the  second  most  common  germ  cell 
tumour, accounting for 20% of all cases, and is common 
in girls and young adults with an average age of 19 years. 
Less  common  germ  cell  tumours  are  embryonal 
carcinoma,  immature  teratoma,  choriocarcinoma, 
polyembryomas, and mixed germ cell tumours.  
Embryonal carcinoma of the ovary is an extremely 
rare  tumour  and  represents  only  about  4  per  cent  of 
malignant  ovarian  germ  cell  tumours  [5].  It  is 
distinguished from a choriocarcinoma by the absence of 
syncytiotrophoblastic  and  cytotrophoblastic  cells  [6]. 
Pure  nongestational  choriocarcinoma  of  the  ovary  is 
extremely rare, as it is nearly always admixed with other 
germ  cell  elements [2].  Histologically,  it  has  the same 
appearance  as  gestational  choriocarcinoma  which 
metastasize to the ovaries [6]. Mixed germ-cell tumours 
of the ovary contain two or more elements of the lesions 
described above. In our case the combination was that of 
embryonal carcinoma and choriocarcinoma. 
Clinically,  a  substantial  majority  of  patients  with 
germ  cell  tumours  present  with  abdominal  pain, 
abdominal distension or a pelvic mass. Approximately 10 
percent  of  patients  will  present  with  acute  abdominal 
pain, usually caused by rupture, haemorrhage, or torsion 
of the ovarian mass. A few patients will exhibit isosexual 
precocity,  presumably  due  to  HCG  production  by  the 
tumour  [7].  Embryonal  carcinomas  may  secrete 
estrogens,  with  the  patient  exhibiting  symptoms  and 
signs of precocious pseudopuberty or irregular bleeding. 
In  the  case  of  non-gestational  choriocarcinoma  the 
presence of high HCG levels causes isosexual precocity 
which  has  been  seen  to  occur  in  about  50  percent  of 
patients  whose  lesions  appear  before  menarche.  In  our 
case, the patient presented with abdominal distension and 
irregular  bleeding  but  there  was  no  evidence  of 
precocious puberty. 
Both  HCG  and  alpha-fetoprotein  are  secreted  by 
some germ cell malignancies, therefore the presence of 
circulating  hormones  may  prove  to  be  useful  in  the 
diagnosis  and  in  monitoring  the  response  to  treatment 
[5,6]. Ultrasonography or CT is helpful in delineating the 
size  and  complexity  of  these  tumours.  Pre-operative 
staging of tumour is possible with CT [1].  
Microscopically  a  dysgerminoma  component  is 
present  in  80  percent,  endodermal  sinus  tumour  in  70 
percent,  immature  teratoma  in  53  percent, 
choriocarcinoma in 20 percent and embryonal carcinoma 
in  16  percent.  A  mixture  of  dysgerminoma  and 
endodermal  sinus  tumour  is  the  most  common 
combination, accounting for one-third of the cases [2]. 
The  immunohistochemical  identification  of  HCG  in 
syncytiotrophoblastic cells indicates a close relationship 
of embryonal carcinoma to choriocarcinoma [4].  
Treatment  consists  of  salpingo-oophorectomy  with 
adjunctive  chemotherapy.  Chemotherapeutic  regimens 
have  evolved  to  combination  therapy  with  overall 
disease- free survival rates of greater than 95 percent [4]. 
Due  to  relatively  low  toxicity  and  ease  of  treatment, 
chemotherapy  has  replaced  radiation  as  the  preferred 
surgical adjuvant even when fertility is not an issue [7]. 
Second-look laparotomy was earlier incorporated into the 
routine  management  of  patients  with  epithelial  ovarian 
cancer to assess disease status after a fixed interval of 
chemotherapy.  However  a  study  conducted  by 
Gynaecologic  Oncology  Group  (GOG)  show  rather 
conclusively  that  second-look  laparatomy  is  not 
necessary  in  patients  with  tumour  completely  resected 
initially or in those patients with initially incompletely 
resected tumour that does not contain teratoma [4,7]. In 
view of malignant germ cell tumours occurring almost 
exclusively  in  young  females,  preservation  of  their 
ovarian function and fertility is becoming an important, 
although controversial, issue in gynaecologic oncology. 
A study by Zanetta et al. confirmed that normal gonadal 
function  and  fertility  are  possible  after  conservative 
surgery  for  ovarian  germ  cell  malignancies,  even  with 
adjuvant chemotherapy [8].  
Mixed germ cell tumour (embryonal carcinoma and 
choriocarcinoma) is a very rare tumour. Orientals may 
have  a  higher  proportion  of  non-dysgerminomatous 
malignant ovarian germ cell tumours when compared to 
reports  in  the  Western  literature  [1].  Careful  initial M. Koshy et al. Biomed Imaging Interv J 2005; 1(2):e10  4 
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surgery  with  adequate  staging  biopsies  followed  by 
combination  chemotherapy  can  greatly  improve  the 
prognosis of these patients [3]. 
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